Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 13
2013 2
2014 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.
Jordan MR, Bennett DE, Wainberg MA, Havlir D, Hammer S, Yang C, Morris L, Peeters M, Wensing AM, Parkin N, Nachega JB, Phillips A, De Luca A, Geng E, Calmy A, Raizes E, Sandstrom P, Archibald CP, Perriëns J, McClure CM, Hong SY, McMahon JH, Dedes N, Sutherland D, Bertagnolio S. Jordan MR, et al. Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S245-9. doi: 10.1093/cid/cis206. Clin Infect Dis. 2012. PMID: 22544182 Free PMC article.
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India.
Hingankar NK, Thorat SR, Deshpande A, Rajasekaran S, Chandrasekar C, Kumar S, Srikantiah P, Chaturbhuj DN, Datkar SR, Deshmukh PS, Kulkarni SS, Sane S, Reddy DC, Garg R, Jordan MR, Kabra S, Tripathy SP, Paranjape RS. Hingankar NK, et al. Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S348-54. doi: 10.1093/cid/cis005. Clin Infect Dis. 2012. PMID: 22544202 Free PMC article.
Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.
Wadonda-Kabondo N, Bennett D, van Oosterhout JJ, Moyo K, Hosseinipour M, Devos J, Zhou Z, Aberle-Grasse J, Warne TR, Mtika C, Chilima B, Banda R, Pasulani O, Porter C, Phiri S, Jahn A, Kamwendo D, Jordan MR, Kabuluzi S, Chimbwandira F, Kagoli M, Matatiyo B, Demby A, Yang C. Wadonda-Kabondo N, et al. Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S362-8. doi: 10.1093/cid/cir987. Clin Infect Dis. 2012. PMID: 22544204 Free PMC article.
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.
Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, Gregson J, Sawyer AW, Hamers RL, Ndembi N, Pillay D, Bertagnolio S. Gupta RK, et al. Lancet. 2012 Oct 6;380(9849):1250-8. doi: 10.1016/S0140-6736(12)61038-1. Epub 2012 Jul 23. Lancet. 2012. PMID: 22828485 Free PMC article.
17 results